Media Library
Past Presentations:

Understanding JAK Inhibitor Treatment Strategies for Patients with Myeloproliferative Neoplasms
John Mascarenhas
Associate Professor of Medicine; Myeloproliferative Disorders Program
Mount Sinai School of Medicine

Building Momentum for Patients with Myelofibrosis
Barbara Klenke
Chief Development Officer
Sierra Oncology

JAK inhibition in COVID-19
Joaquin Espinosa
Professor of Pharmacology
University of Colorado School of Medicine